Diabetic Foot Ulcers Treatment Market

Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the patients with diabetes mellitus and diabetes insipidus, which also leads to chronic foot wounds due to minor trauma or pressure.

Diabetic Foot Ulcers Treatment Market contains market size and forecasts of Diabetic Foot Ulcers Treatment in global, including the following market information:

Global Diabetic Foot Ulcers Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Diabetic Foot Ulcers Treatment Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Diabetic Foot Ulcers Treatment companies in 2021 (%)

The global Diabetic Foot Ulcers Treatment market was valued at 5416.8 million in 2021 and is projected to reach US$ 9617 million by 2028, at a CAGR of 8.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Foot Ulcers Treatment include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc, Smith & Nephew Plc, Medtronic Plc, ConvaTec Inc, Molnlycke Health Care and Organogenesis, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diabetic Foot Ulcers Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Foot Ulcers Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, by Type, 2021 (%)

Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings)

Biologics (Growth factors, and Skin Graft and Skin Substitute)

Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)

Global Diabetic Foot Ulcers Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinics

Ambulatory Surgical Center

Homecare Setting

Global Diabetic Foot Ulcers Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Foot Ulcers Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Diabetic Foot Ulcers Treatment revenues share in global market, 2021 (%)

Key companies Diabetic Foot Ulcers Treatment sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Diabetic Foot Ulcers Treatment sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

3M Healthcare

Coloplast A/S

B.Braun Melsungen AG

Acelity L.P. Inc

Smith & Nephew Plc

Medtronic Plc

ConvaTec Inc

Molnlycke Health Care

Organogenesis, Inc.

Derma Sciences Inc.

Sigvaris Inc.